Part II: Risk-Based Monitoring – Putting into Practice
In order to maximize benefits of Risk Based Monitoring (RBM), the drug / device development companies, CROs are actively looking into implementation of it into practice. After getting proper perspectives on RBM, it is utmost important to have a right start to put RBM into practice to ensure effective use of RBM approach. Along with identification and evaluation of risks to critical study data & clinical trial operations, it is very imperative to ponder over processes structuring, people alignment and necessary technology requirements to ensure high quality of data, enhance human subject protection, reduce cost and build high efficiencies across clinical trial processes.
After overwhelming response to Part I: Risk-Based Monitoring – Putting into Context, MakroCare takes pleasure to present the Part II of this webinar.
Part II : Risk-Based Monitoring – Putting into Practice
- What may generate risk?
- Risk management documentation/risk statement structure
- How to get started
- Actions and how to manage them
- Practical Implications
Independent Risk Management Consultant and Trainer, UK
Head of Education and Training
The Institute of Clinical Research, UK
Ashok K. Ghone, PhD
VP, Global Services
Date & Time :
Date : Wednesday, 5th June 2013
Time : 11:00 – 12:00 hrs US EST /16:00 – 17:00 hrs UK BST
Cost : None
Click Here to Register for Webinar or sent an e-mail to firstname.lastname@example.org